【SanBio】Notice of Non-Operating Income and Corporate Tax Adjustment for Q1 FY2026｜June 15, 2026

Overview of Performance

In the first quarter from February 1 to April 30, 2026, SanBio recorded foreign exchange gains of 177 million yen due to fluctuations in the exchange rates. This was mainly caused by foreign currency-denominated loans and related receivables, along with a foreign exchange translation adjustment of -136 million yen. Additionally, the company recognized a corporate tax adjustment of 55 million yen due to the recognition of deferred tax liabilities related to foreign currency-denominated loans. These items have had a certain impact on the performance.

Future Outlook and Investor Impact

The foreign exchange gains and tax adjustments recognized this time are attributable to temporary exchange rate fluctuations, and their long-term impact on future performance remains uncertain. SanBio is actively reviewing its foreign exchange risk management and tax strategies, and attention should be paid to upcoming financial summaries and earnings guidance. Investors need to consider the impact of exchange rate fluctuations while evaluating the company’s risk management and medium- to long-term business strategies.